Tuesday, May 26, 2015 6:34:03 PM
However, I am beginning to think that KBLB must first reach the $2.00 range before a buyout occurs. From that PPS, a jump to $15.00 plus is much easier than from .044. Frankly, I feel there are many things going on behind the scenes involving perhaps more than one company.
It may also be that a buyout is in the works right now. That is a distinct possibility. The secrecy is just too long and too guarded for something big not to be happening. WM is as quiet as a church mouse, and the vault at KBLB is sealed shut!
Again, I also feel the DOD is involved with KBLB, further adding to the shroud of secrecy. I am sure tired of waiting to see what is happening, but I feel whatever it is, it is big.
Nonetheless, I still cannot see KBLB going for anything less than $15.00. The ten billion dollar price tag for a purchase at this price is still way too cheap for the holy grail. DD knows this I am sure.
IMHO, I even believe $20.00 is too cheap. At the price, it still only comes to less than 14 billion, chump change for the growth KBLB offers.
I am certain Kim knows this also, and this is what his ultimate goal is, IMHO.......
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM